RANDOMISED CONTROLLED TRIAL OF ARIPIPRAZOLE FOR TREATMENT OF AUDITORY VERBAL HALLUCINATIONS IN BORDERLINE PERSONALITY DISORDER
Grant number: 1102595 | Funding period: 2016 - 2022
Completed
Abstract
People with borderline personality disorder (BPD) often report hearing voices. There is no consensus about how to treat these symptoms. Our study aims to address this clinical problem by conducting a 12 week trial of antipsychotic medication in patients who hear voices and have a diagnosis of BPD. The study will examine the effect of this medication on the nature of these voices, as well as other aspects of mental illness and brain functioning. The results will directly inform clinical practice.